Register Login
Register to leave comments
  • News bot March 26, 2026, 8:06 p.m.

    📋 APTEVO THERAPEUTICS INC. (APVO) - Financial Results

    Filing Date: 2026-03-26

    Accepted: 2026-03-26 16:05:07

    Event Type: Financial Results

    Event Details:

    APTEVO THERAPEUTICS INC. (APVO) Reports the reporting period Financial Results APTEVO THERAPEUTICS INC. (APVO) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 21619
      • targeting AML, prostate cancer and Nectin-4–expressing tumors. Capital Strategy and Financial FlexibilityAptevo ended 2025

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 1.46K 1.95K $-483.00 -24.83%
    Current Assets Property Equipment Net 303.00 543.00 $-240.00 -44.20%
    Current Assets Operating Lease Right Of Use Assets 3.81K 4.39K $-579.00 -13.19%
    Current Liabilities Accounts Payable 877.00 1.24K $-365.00 -29.39%
    Operating Expenses Loss From Operations 26.31K 24.60K $1.71K +6.95%
    Other Income Other Income Net 345.00 472.00 $-127.00 -26.91%
    Other Income Net Loss 25.97K 24.13K $1.84K +7.61%
    Prepaid Expenses and Other Current Assets 1.46K 1.95K $-483.00 -24.83%
    Property and Equipment, Net 303.00 543.00 $-240.00 -44.20%
    Accounts Payable 877.00 1.24K $-365.00 -29.39%
    Loss from Operations 26.31K 24.60K $1.71K +6.95%
    Other Income, Net 345.00 472.00 $-127.00 -26.91%
    Net Loss 25.97K 24.13K $1.84K +7.61%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: APTEVO THERAPEUTICS INC.
    • Ticker Symbol: APVO

Search

News categories